EA
TARO

Emerald Acquisition’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Emerald Acquisition’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$1.59M Sell
14,436
-32,284
-69% -$4.28M ﹤0.01% 1871
2016
Q2 		$6.8M Buy
+46,720
New +$6.63M 0.01% 1143

Other funds holding TARO

Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
MICM
Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Emerald Acquisition's TARO Position: Q3 2016 in Review

Emerald Acquisition reduced its Taro Pharmaceutical Industries Ltd. (TARO) stake by 69% in Q3 2016, selling an estimated $4.28M and leaving 14,436 shares worth $1.59M. The position accounts for ﹤0.01% of the portfolio, ranked #1871.

Emerald Acquisition first reported a position in TARO in Q2 2016 and has held it in 2 quarters since. The position peaked at $6.8M in Q2 2016. 162 funds tracked by Wall St. Rank hold TARO as of Q3 2016.

  • Emerald Acquisition held 14,436 shares of Taro Pharmaceutical Industries Ltd. worth $1.59M as of Q3 2016.
  • Emerald Acquisition sold 32,284 Taro Pharmaceutical Industries Ltd. shares in Q3 2016, an estimated $4.28M.
  • Taro Pharmaceutical Industries Ltd. made up ﹤0.01% of Emerald Acquisition's portfolio in Q3 2016, its #1871 holding.
  • Emerald Acquisition first reported a position in Taro Pharmaceutical Industries Ltd. in Q2 2016 and has held it in 2 quarters since.
  • Emerald Acquisition's Taro Pharmaceutical Industries Ltd. position peaked at $6.8M in Q2 2016.
  • 162 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.